|
| Press Releases |
|
 |
|
| Friday, March 21, 2025 |
|
|
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum |
| On March 17, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 annual results. The Company recorded a turnover of RMB7,469 million, representing a year-on-year decrease of 6.8%; in the case that all medicines were directly sold by the Company, the turnover would be RMB8,622 million, representing a year-on-year decrease of 9.0%. more info >> |
|
| Friday, February 14, 2025 |
|
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
| In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited ("CMS" or the "Group") has been included in the S&P Global Sustainability Yearbook 2025 (the "Yearbook 2025"). more info >> |
|
| Friday, January 24, 2025 |
|
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
| China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 more info >> |
|
| Thursday, January 9, 2025 |
|
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
| Monday, December 9, 2024 |
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China |
| China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China more info >> |
|
| Monday, December 2, 2024 |
|
|
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia |
| China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia more info >> |
|
| Monday, October 21, 2024 |
|
|
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area |
| China Medical System Holdings Limited (the "Group" or "CMS") is pleased to announce that on 18 October, the first batch of prescriptions of ruxolitinib phosphate cream (the "ruxolitinib cream" or the "Product") for qualified vitiligo patients were issued in the Greater Bay Area, at Zhongshan Chen Xinghai Hospital of Integrated Traditional Chinese and Western Medicine, Foshan Fosun Chancheng Hospital, and Dongguan Songshan Lake Tungwah Hospital. more info >> |
|
| Tuesday, September 24, 2024 |
|
|
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for vitiligo indication of ruxolitinib phosphate cream (the "ruxolitinib cream" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
| Friday, August 16, 2024 |
|
|
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023 |
| On August 15, 2024, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 interim results announcement, with a steady increase in overall revenue and profit for the period compared to the second half (2H) of 2023. In the first half (1H) of 2024, the Company recorded a turnover of RMB3,611.1 million, representing a decrease of 21.7% compared with 1H 2023, an increase of 6.1% compared with 2H 2023. more info >> |
|
| Monday, August 5, 2024 |
|
|
China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 30 July 2024, the New Drug Application (NDA) for an additional indication of Methotrexate Injection (the "Product") has been approved by the National Medical Products Administration of China (NMPA). more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Thailand's Brewing Industry Gets a Boost with Life Below Labs' Local Yeast Hub
Apr 17, 2025 10:00 HKT/SGT
|
|
|
Standard Chartered GBA Business Confidence Survey shows calm before tariff storm in Q1
Apr 17, 2025 09:31 HKT/SGT
|
|
|
GA-ASI Announces Technology Investments From Blue Magic Netherlands
Apr 17, 2025 01:00 HKT/SGT
|
|
|
HODL 2025: Blockchain's Brightest Minds. All in Dubai
Apr 16, 2025 23:59 HKT/SGT
|
|
|
analytica Vietnam 2025 Concludes with Record-Breaking Attendance and Exhibitor Participation
Apr 16, 2025 23:55 HKT/SGT
|
|
|
Kincora Copper: Investor Briefing Webinar - Sixth Asset Level Agreement
Apr 16, 2025 23:44 HKT/SGT
|
|
|
InnoEX and Spring Electronics Fair attract some 88,000 global buyers
Apr 16, 2025 20:28 HKT/SGT
|
|
|
FXDyno's AI-Powered Wave Trading Set to Redefine Gold Trading
Apr 16, 2025 19:00 HKT/SGT
|
|
|
Global Logistics Industry Revolution, Reitar Logtech Launches the First Humanoid Logistics Robot 
Apr 16, 2025 17:37 HKT/SGT
|
|
|
'The Sound of Chunhyang Opens the World' - The 95th Namwon Chunhyang Festival to Kick Off on April 30
Apr 16, 2025 15:30 HKT/SGT
|
|
|
PCG's Fruitful Achievements in 1Q2025
Apr 16, 2025 14:35 HKT/SGT
|
|
|
Fujitsu's Japanese language enhanced LLM Takane offering now available on Nutanix Enterprise AI solution
Apr 16, 2025 11:24 JST
|
|
|
TransNusa Becomes First Indonesian Airline to Launch Scheduled Bali - Guangzhou Route
Apr 16, 2025 09:38 HKT/SGT
|
|
|
Euro Manganese Announces Early Appointment of Chairman and Provides Financing Update
Apr 16, 2025 03:40 HKT/SGT
|
|
|
Kincora Copper: Second Major Earn-In Secured with AngloGold Ashanti
Apr 16, 2025 03:23 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
